PHASE I-II TRIAL OF IMATINIB MESYLATE (GLEEVEC; STI571) IN TREATMENT OF RECURRENT OLIGODENDROGLIOMA AND MIXED OLIGOASTROCYTOMA. NORTH CENTRAL CANCER TREATMENT GROUP STUDY N0272 (AL...

nork Jaeckle, Kurt A., Anderson, S K., Twohy, Erin L., Dixon, Jesse G., Giannini, Caterina, Jenkins, Robert, Egorin, Merrill J., Sarkaria, Jann N., Brown, Paul D., Flynn, P J., Schwerkoske, John, Buckner, Jan C., Galanis, Eva
Argitaratua izan da J Neurooncol (2019)

Correction to: Phase I–II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group...

nork Jaeckle, Kurt A., Anderson, S. K., Twohy, Erin L., Dixon, Jesse G., Giannini, Caterina, Jenkins, Robert, Egorin, Merrill J., Sarkaria, Jann N., Brown, Paul D., Flynn, P. J., Schwerkoske, John, Buckner, Jan C., Galanis, Evanthia
Argitaratua izan da J Neurooncol (2019)

A Phase I and Randomized Placebo-Controlled Phase II Trial of Bevacizumab plus Dasatinib in Patients with Recurrent Glioblastoma (GBM): Alliance/NCCTG N0872

nork Galanis, Evanthia, Anderson, S. Keith, Twohy, Erin L., Carrero, Xiomara W., Dixon, Jesse G., Tran, David Dinh, Jeyapalan, Suriya A., Anderson, Daniel M., Kaufmann, Timothy J., Feathers, Ryan W., Giannini, Caterina, Buckner, Jan C., Anastasiadis, Panos Z., Schiff, David
Argitaratua izan da Cancer (2019)

Stereotactic Radiosurgery with or without Whole Brain Radiotherapy for Limited Brain Metastases: A Secondary Analysis of the NCCTG N0574 (Alliance) Randomized Controlled Trial

nork Churilla, Thomas M., Ballman, Karla V., Brown, Paul D., Twohy, Erin L., Jaeckle, Kurt, Farace, Elana, Cerhan, Jane H., Anderson, S. Keith, Carrero, Xiomara W., Garces, Yolanda I., Barker, Fred G., Deming, Richard, Dixon, Jesse G., Burri, Stuart H., Chung, Caroline, Ménard, Cynthia, Stieber, Volker W., Pollock, Bruce E., Galanis, Evanthia, Buckner, Jan C., Asher, Anthony L.
Argitaratua izan da Int J Radiat Oncol Biol Phys (2017)